Novel Therapeutic Effects of the Anti-Convulsant, Zonisamide, on Parkinson's Disease

E-ISSN： 1873-4286|10|6|687-693

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.6, 2004-02, pp. : 687-693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zonisamide: In Parkinson's Disease

By Yang Lily P.H. Perry Caroline M.

CNS Drugs, Vol. 23, Iss. 8, 2009-08 ,pp. : 703-711

Adis International

Access to resources Recommend Favorite

Zonisamide in Parkinson's Disease†: Profile Report

By Yang Lily P.H. Perry Caroline M.

Drugs & Aging, Vol. 27, Iss. 1, 2010-01 ,pp. : 73-75

Adis International

Access to resources Recommend Favorite

Novel anti-inflammatory therapy for Parkinson's disease

By Gao H.-M. Liu B. Zhang W. Hong J.-S.

Trends in Pharmacological Sciences, Vol. 24, Iss. 8, 2003-08 ,pp. : 395-401

Elsevier

Access to resources Recommend Favorite

High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1480-1493

Bentham Science Publishers

Access to resources Recommend Favorite

-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson’s Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 630-637

Bentham Science Publishers

Access to resources Recommend Favorite